Table 3.
Selected publications reporting outcomes of hepato-pancreaticoduodenectomy
| Series | Number of patients | Morbidity | Mortality | Fraction of patients who underwent preoperative PVE | 5 year OS |
|---|---|---|---|---|---|
| Miwa et al.33 | 26 | 30.8% | 0% | 77% | 25% (GBC) 51.9% (BDC) |
| Wakai et al.19 | 28 | 82% | 21% | 0 | 9% (GBC) 12%(BDC) |
| Kaneoka et al.31 | 14 | 57% | 0% | 43% | 50% |
| Ebata et al.30 | 78 | 77% | 2.4% | 79% | 54% (BDC) |
| Lim et al.32 | 23 | 91% | 31% | 0 | 10% (GBC) 32.3% (BDC) |
| Sakamoto et al.34 | 19 | 95% | 5% | 89% | 0% (GBC) 53% (BDC) |
PVE, portal vein embolization; GBC, gallbladder cancer; BDC, bile duct cancer; OS, overall survival.